Skip to main content
. 2017 Jul 3;7:4546. doi: 10.1038/s41598-017-04874-4

Figure 2.

Figure 2

HSP90 is increased in PAH-PASMCs and stabilizes HDAC6 expression. (A) HSP90 expression was assessed by Western blot in pulmonary artery smooth muscle cells (PASMCs) from control (n = 3) and PAH patients (n = 5) and distal PAs from control (n = 3), MCT (n = 3) and Su/Hx (n = 3) rats. Protein band densitometry is reported in the corresponding graph. (B) Expression of HDAC6, acetylated-α-Tubulin, and α-Tubulin was assessed in PAH-PASMCs by Western blot after treatment or not with a pharmacological HSP90 inhibitor (AT13387, 10–100 nM for 48 hours) or vehicle (dimethyl sulfoxide). (C) Expression of HSP90, HDAC6, acetylated-α-Tubulin, and α-Tubulin was assessed in PAH-PASMCs by Western blot after treatments with a siHSP90 or siSCRM (20–100 nM for 48 hours). Blots are representative of two independent experiments. *P < 0.05.